Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517 |
filingDate |
2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2019-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2019528267-A |
titleOfInvention |
GABA (A) receptor modulator and method for inhibiting airway hyperresponsiveness and inflammation in asthma |
abstract |
Pyrrolobenzodiazepines target alpha-4 and alpha-5 GABA A receptors for use in treating airway hyperresponsiveness and inflammation in asthma. The compound was selectively distributed to the peripheral fraction and reduced CNS action. |
priorityDate |
2016-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |